Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Webinar by Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors in Advanced NSCLC
Author
Howard (Jack) West, MD

Two weeks from now (March 9, 3 PM EST/noon PST), Dr. Lecia Sequist of Massachusetts General Hospital will lead a free online webinar that is a joint program between GRACE and LUNGevity, on the topic of "Acquired Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): What We Know Now, and How We’re Moving Forward", to be followed by an interactive Q&A session.

lecia-seqist1 Dr. Sequist is a medical oncologist and Assistant Professor of Medicine, Harvard Medical School; Center for Thoracic Cancers, Massachusetts General Hospital Cancer Center, and she is also one of the people at the forefront of management questions for patients with an activating EGFR mutation.

Some highlight issues we'll plan to cover:

1. What is known about the timing of development of acquired resistance to oral EGFR TKIs?

2. Is there anything known about ways to postpone acquired resistance?

3. Once progression is documented, is there anything to be done to restore/improve activity of these agents?

4. Are there data to speak to concept of continuing an EGFR TKI while adding chemo or some other agent, vs. stopping it at progression and switching to new therapy?

5. What is known about mechanisms of acquired resistance and any differences in clinical behavior and outcomes among these?

6. What practically useful information can be gained from re-biopsy at progression?

7. What are practical barriers to re-biopsy at progression?

8. What clinical trials are available for motivated patients?

Although this topic is most directly relevant to the minority of lung cancer patients with an activating EGFR mutation, the question of how to manage acquired resistance after a good initial response is a timely issue that is becoming increasingly relevant in our increasingly molecularly-defined approach to lung cancer.

For those interested and able to attend the live program, you can register here (registration info to be shared between GRACE and LUNGevity). For those who can't attend the live event or who don't want to worry about taking notes, we'll make this content available as a free podcast (audio or video) for everyone.

Next Previous link

Previous PostNext Post

Related Content

Article
Imagine your body's defense system, the lymphatic system, suddenly turning against you. This is the reality for those facing lymphoma, a cancer of the immune system's crucial network. This article delves into the complexities of lymphoma, exploring its various forms, from the aggressive to the indolent, and examining the latest breakthroughs in treatment, including the groundbreaking POLARIX trial and cutting-edge therapies for relapsed cases. Whether you're a patient, a loved one, or simply curious about this complex disease, this comprehensive overview will provide valuable insights into the current state of lymphoma care and the promising future of research.
Image
Melanoma Video Library
Video
In these videos, Dr. Autumn Starnes gives an overview of melanoma's prevalence and risk factors. She also discusses the ABCDE method of self-screening for skin cancer, common misconceptions regarding people of color, and melanoma, and how a person can lower their risk of developing melanoma, among other relevant topics regarding melanoma.  To watch the complete playlist, click here. 
Image
Tumor Treating Fields 2023
Video
In this video, GRACE provides an overview of Tumor Treating Fields, a wearable device that may be used to treat mesothelioma and glioblastoma multiforme.  Video Transcript.

Recent Comments

JOIN THE CONVERSATION
Z, Don't apologize for…
By JanineT GRACE … on
Rukenk,

Please let us know…
By JanineT GRACE … on
Thank you Janine
By rukenk on
Sorry understood I think I…
By zhengchenji18 on